$GBT treats one of the most prevalent diseases that afflicts black Americans (sickle cell disease). The company has a large short interest and at these depressed prices is an excellent takover candidate . A leading Oppenheimer analyst that has an impeccable track record has a price target roughly 130% higher. JPM analyst downgraded stock today which presents interesting entry point.
Bottom line : most of us have made a significant amount of money on this site and market in general lets pay forward and make a difference and help fund a company that truly makes a difference for black lives and make a fortune while doing so.